immune disorders 2: 272
inborn disorders of metabolism
4 :227
karyotype 4: 133
Klinefelter’s syndrome 3: 296
Marfan syndrome 1:335–336
MEN 3:151, 152
methemoglobinemia 2: 157
muscular dystrophy 1:337–339
mutation 4: 135
myopathy 1: 340
myotonia 1: 340
neurofibromatosis 1:269
nevus 1: 178
osteogenesis imperfecta
1:342–343
osteopetrosis 1:344–345
polydactyly 1:350, 350
RTA 3: 219
SCID 2:294
skeletal dysplasia 1:355
syndactyly 1:357
von Willebrand’s disease 2: 174
Wilson’s disease 3: 168
genetic imprinting 4: 117 , 129
genetic predisposition 1:222; 2:114,
145, 193, 216, 241, 243; 4: 129 ,
129–130, 135
genetics and molecular medicine
4:109–144
genetic screening 4:130
amniocentesis 3: 244
autism 3: 364
cystic fibrosis 4: 121
ethical issues in genetics and
molecular medicine 4: 124
gastrointestinal system 3: 7
HNPCC 3: 58
karyotype 4: 133
MEN 3: 151
polycystic kidney disease 3: 214
Turner’s syndrome 3: 348
genetic testing 1:136, 155; 2:33,
170, 202, 369; 4:130–131
congenital anomaly 4: 120
ethical issues in genetics and
molecular medicine 4: 124
fragile X syndrome 4: 126
genetics and molecular medicine
4: 112
genetic screening 4: 130
porphyria 4: 138
Tay-Sachs disease 4: 142
genital herpes 2:327–329, 328 t,
332; 3:339, 340
genitalia 3:287
genital trauma 3:287–288
genitourinary tract 3:186, 362
genome 4:109–110, 114, 131, 143
genotype 4:110, 130, 131,136, 143
GERD. Seegastroesophageal reflux
disorder
German measles. Seerubella
germ cells 4:115, 127
germline mutations 1:114; 4: 135
gestation 3:272, 324
gestational diabetes 3:119, 120,
271 , 288–289, 321
gestational surrogacy 3:242, 282,
289
GH. Seegrowth hormone
GHRH. Seegrowth hormone-
releasing hormone
giant-cell arteritis 1:98; 2: 300 t
giardiasis 2:329, 329 t
ginger 2:243, 376; 4:70, 70 t
gingivitis 1:25
ginkgo biloba 1:223, 244; 4:70–71,
71 , 71 t, 177
ginseng 4:71–72, 71 t, 72 t, 231 , 348
glaucoma 1:92–94, 93 t;4: 326
cataract 1: 78
eye pain 1: 90
eyes 1: 67
Graves’s ophthalmopathy 1: 94
intraocular pressure 1: 97
mydriasis 1: 100
ocular herpes zoster 1: 103
tonometry 1: 119
glomeruli 3:173, 176, 202,
210–212
glomerulonephritis 3: 176 ,
191–192, 207
glomerulosclerosis 3:192–193
glomerulus 3:169, 192, 193,201,
209
glossitis 1:25
glossopharyngeal nerve 1:49, 53
glucagon 3:79, 100, 128,128, 149
glucosamine 1:366; 4: 64 , 72–73,
73 t
glucose 1:77, 285, 377; 2:49, 118,
120; 3:128, 128 t
appetite 4: 178
beriberi 4: 179
carbohydrate loading 4: 217
diabetes 3: 119
endocrine system 3: 100
gestational diabetes 3: 288
glucagon 3: 128
insulin 3: 148
insulin resistance 3: 149metabolism 4: 225
nephropathy 3: 210
nutrients 4: 190
obesity and health 4: 301
protein loading 4: 229
urinary system 3: 173
glutamate 1:224; 4:316–317, 330
glutethimide 4:336
glycogen 3:128, 142, 148; 4:217,
220, 229
GnRH. Seegonadotropin-releasing
hormone
goiter 3: 127 , 128–129, 146
goldenseal 2:76, 237, 239; 4:73, 73 t
gonadotropin-releasing hormone
(GnRH) 3:129
aging and endocrine changes
3: 110
androgens 3: 113
estrogens 3: 126
FSH 3: 127
hypothalamus 3: 145
inhibin 3: 148
LH 3: 151
prolactin 3: 157
uterine fibroids 3: 350
gonorrhea 1:80; 2:329–330, 330 t;
3:277, 340; 4: 150
Goodpasture’s syndrome 3:193,
193 t
Good Samaritan laws 4:358, 358
goose bumps 1:160–161
gout 1:323–324, 324 t
grading, of cancer. Seestaging and
grading of cancer
graft vs. host disease 1:173;
2:263–265, 264 t;3:76, 150
bone marrow transplantation
2: 133
cell-mediated immunity 2: 253
complement cascade 2: 255
corticosteroid medications 2: 256
HLAs 2: 267
immunosuppressive medications
2: 276
immunosuppressive therapy
2: 276
MHC 2: 282
granulocyte 2:138–139
granuloma 2:265
human ehrlichiosis 2: 335
immune system 2: 235
leukocyte 2: 120
lymph 2: 120
lymphocyte 2: 152
neutropenia 2: 161472 Index